Adenovirus News and Research

RSS
Adenoviruses most commonly cause respiratory illness; however, depending on the infecting serotype, they may also cause various other illnesses, such as gastroenteritis, conjunctivitis, cystitis, and rash illness. Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress.
Novel adenovirus-based gene therapy for renal cell carcinoma

Novel adenovirus-based gene therapy for renal cell carcinoma

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

Cytheris' combinational therapy demonstrates possible therapeutic strategy for PML

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

BioSante announces sale of oncolytic virus technology to Cold Genesys

BioSante announces sale of oncolytic virus technology to Cold Genesys

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

Idaho seeks FDA marketing clearance for FilmArray Respiratory Panel

Idaho seeks FDA marketing clearance for FilmArray Respiratory Panel

Virus fighting just got a new boost

Virus fighting just got a new boost

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

NIAID announces three new contracts to fund research on dengue, anthrax vaccines

NIAID announces three new contracts to fund research on dengue, anthrax vaccines

NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants

NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants

UAB Comprehensive Cancer Center wins $11.5M grant for pancreatic cancer research

UAB Comprehensive Cancer Center wins $11.5M grant for pancreatic cancer research

Oncolytics Biotech receives patent for modified reovirus variant

Oncolytics Biotech receives patent for modified reovirus variant

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Childhood obesity linked to common cold virus

Childhood obesity linked to common cold virus

Adenovirus exposure may cause obesity in children: Study

Adenovirus exposure may cause obesity in children: Study

Chimerix presents promising clinical data for CMX001 in late-breaker poster session at 50th ICAAC

Chimerix presents promising clinical data for CMX001 in late-breaker poster session at 50th ICAAC

Research on immune system can develop new therapy for inflammation, tumors

Research on immune system can develop new therapy for inflammation, tumors